OncoSec takes a 10% hit - but stocks gain 1.4% on average overall.

There was broad-based gain of 1.4% with 22 stocks gaining ground.  Generex had the biggest gain of over 5%, while BioNTech pick up just under 5%.

Onco Sec took another hit, falling almost 10% to lead on the downside.